Dahlin, J.L.* ; Auld, D.S.* ; Rothenaigner, I. ; Haney, S.* ; Sexton, J.Z.* ; Nissink, J.W.M.* ; Walsh, J.* ; Lee, J.A.* ; Strelow, J.M.* ; Willard, F.S.* ; Ferrins, L.* ; Baell, J.B.* ; Walters, M.A.* ; Hua, B.K.* ; Hadian, K. ; Wagner, B.K.*
Nuisance compounds in cellular assays.
Cell Chem. Bio. 28, 356-370 (2021)
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity (“nuisance compounds”) are routinely encountered in cellular assays, including phenotypic and high-content screening assays. Much is known regarding compound-dependent assay interferences in cell-free assays. However, despite the essential role of cellular assays in chemical biology and drug discovery, there is considerably less known about nuisance compounds in more complex cell-based assays. In our view, a major obstacle to realizing the full potential of chemical biology will not just be difficult-to-drug targets or even the sheer number of targets, but rather nuisance compounds, due to their ability to waste significant resources and erode scientific trust. In this review, we summarize our collective academic, government, and industry experiences regarding cellular nuisance compounds. We describe assay design strategies to mitigate the impact of nuisance compounds and suggest best practices to efficiently address these compounds in complex biological settings. Nuisance compounds can waste significant resources by producing promising bioactivities that are attributable to undesirable mechanisms of action. Addressing nuisance compounds is particularly challenging in cellular assays. Dahlin et al. summarize academic, government, and industry experiences with assay design and hit triage to specifically address cellular nuisance compounds.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Artifacts ; Chemical Biology ; Drug Discovery ; High-content Screening ; High-throughput Screening ; Interference ; Nuisance Compounds ; Phenotypic Drug Discovery ; Phenotypic Screening; High-throughput Identification; Small-molecule; Natural-products; Cancer-cells; Drug; Interference; Inhibition; Discovery; Stability; Targets
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
HGF-Berichtsjahr
2021
ISSN (print) / ISBN
2451-9448
e-ISSN
2451-9456
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 28,
Heft: 3,
Seiten: 356-370
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Cell Press
Verlagsort
Cambridge, Massachusetts
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-505293-001
Förderungen
NIDDK NIH HHS
NHLBI NIH HHS
Copyright
Erfassungsdatum
2021-04-26